Nyural provides AI-driven risk assessment tools that analyze genetic data to determine the likelihood of developing neurodegenerative diseases such as Alzheimer's, Huntington's, and Parkinson's. This technology enables early detection and personalized insights, allowing individuals to take proactive steps in managing their neurological health.
Funding
Funding not disclosed
Founders
Product
Problem
Millions worldwide are affected by the rising rates of neurodegenerative diseases like Alzheimer's, Huntington's, and Parkinson's. Early detection and risk assessment are crucial for effective management of these conditions.
Solution
Nyural provides AI-driven risk assessment tools that analyze genetic data to determine an individual's likelihood of developing neurodegenerative diseases. The platform offers early warnings and personalized insights, empowering individuals to take proactive steps in managing their neurological health. By identifying potential risks early on, Nyural enables timely intervention and personalized care strategies. The AI algorithms analyze complex genetic markers associated with these diseases to provide a comprehensive risk profile.
Target Audience
Individuals concerned about their risk of developing neurodegenerative diseases, as well as healthcare providers seeking advanced diagnostic tools.
Features
- AI-driven analysis of genetic data for neurodegenerative disease risk assessment
- Personalized risk reports with actionable insights
- Early detection of potential neurological conditions